Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine

With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine. In this paper, the adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaosong, Min, Min, Du, Nan, Gu, Ying, Hode, Tomas, Naylor, Mark, Chen, Dianjun, Nordquist, Robert E., Chen, Wei R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603646/
https://www.ncbi.nlm.nih.gov/pubmed/23533454
http://dx.doi.org/10.1155/2013/387023
_version_ 1782263706657226752
author Li, Xiaosong
Min, Min
Du, Nan
Gu, Ying
Hode, Tomas
Naylor, Mark
Chen, Dianjun
Nordquist, Robert E.
Chen, Wei R.
author_facet Li, Xiaosong
Min, Min
Du, Nan
Gu, Ying
Hode, Tomas
Naylor, Mark
Chen, Dianjun
Nordquist, Robert E.
Chen, Wei R.
author_sort Li, Xiaosong
collection PubMed
description With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine. In this paper, the adjuvant properties of chitin and chitosan were discussed, and some detailed information about glycated chitosan and chitosan nanoparticles was also presented to illustrate the trend for future development.
format Online
Article
Text
id pubmed-3603646
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36036462013-03-26 Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine Li, Xiaosong Min, Min Du, Nan Gu, Ying Hode, Tomas Naylor, Mark Chen, Dianjun Nordquist, Robert E. Chen, Wei R. Clin Dev Immunol Review Article With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine. In this paper, the adjuvant properties of chitin and chitosan were discussed, and some detailed information about glycated chitosan and chitosan nanoparticles was also presented to illustrate the trend for future development. Hindawi Publishing Corporation 2013 2013-03-04 /pmc/articles/PMC3603646/ /pubmed/23533454 http://dx.doi.org/10.1155/2013/387023 Text en Copyright © 2013 Xiaosong Li et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Li, Xiaosong
Min, Min
Du, Nan
Gu, Ying
Hode, Tomas
Naylor, Mark
Chen, Dianjun
Nordquist, Robert E.
Chen, Wei R.
Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
title Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
title_full Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
title_fullStr Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
title_full_unstemmed Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
title_short Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
title_sort chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603646/
https://www.ncbi.nlm.nih.gov/pubmed/23533454
http://dx.doi.org/10.1155/2013/387023
work_keys_str_mv AT lixiaosong chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT minmin chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT dunan chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT guying chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT hodetomas chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT naylormark chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT chendianjun chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT nordquistroberte chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine
AT chenweir chitinchitosanandglycatedchitosanregulateimmuneresponsesthenoveladjuvantsforcancervaccine

Ejemplares similares